4
Changes in Ownership
ImmunityBio, Inc. Filed Acc 0001209191-21-003421
Chief Financial Officer sold 16,364 shares at $15.00 ($245,460)
- Chief Financial Officer acquired 11,364 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nelson Sonja Chief Financial Officer | 2021-01-12 | Option exercise | +11,364 | $3.07 | $34,887 | 31,774 | D: show line 1 in the form |
| Nelson Sonja Chief Financial Officer | 2021-01-12 | Sale | −16,364 | $15.00 | $245,460 | 15,410 | D: show line 2 in the form |
| Open-market sales · 16,364 sh · avg $15.00 · $245,460 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nelson Sonja Chief Financial Officer | 2021-01-12 | Option exercise · Stock Option (right to buy) | −11,364 | 165,907 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…